recombinant Factor VIII (rAHF-PFM)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant Factor VIII (rAHF-PFM), covering 2021-04-27 to 2021-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A [Phase 2, Phase 3]